Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (251-260 of 397) with videos related to

Pageof 40
Sort By:
Molecular Cancer Therapeutics|April 17, 2008
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyJudith A Gilbert, Matthew P Goetz, Carol A Reynolds, et al.
Cancer Research|December 5, 2022
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast CancerLixuan Wei, Huanyao Gao, Jia Yu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancerSteven E Schild, Philip J Stella, Susan M Geyer, et al.
JAMA Network Open|February 3, 2023
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010Carolyn M Larsen, Mariana Garcia Arango, Harika Dasari, et al.
Investigational New Drugs|October 12, 2013
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabineMatthew P Goetz, Heidi A McKean, Joel M Reid, et al.
Human Immunology|June 18, 2020
Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA typeAnn M Moyer, Brian Dukek, Patti Duellman, et al.
Breast Cancer Research and Treatment|October 21, 2024
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108Vered Stearns, Anne ONeill, Bryan P Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2023
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast CancerMatthew P Goetz, Erika P Hamilton, Mario Campone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashesMatthew P Goetz, James M Rae, Vera J Suman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)H H Yoon, N R Foster, J P Meyers, et al.
Pageof 40

Showing results (251-260 of 397) with videos related to

Sort By:
Pageof 40
Molecular Cancer Therapeutics|April 17, 2008
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyJudith A Gilbert, Matthew P Goetz, Carol A Reynolds, et al.
Cancer Research|December 5, 2022
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast CancerLixuan Wei, Huanyao Gao, Jia Yu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancerSteven E Schild, Philip J Stella, Susan M Geyer, et al.
JAMA Network Open|February 3, 2023
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010Carolyn M Larsen, Mariana Garcia Arango, Harika Dasari, et al.
Investigational New Drugs|October 12, 2013
UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabineMatthew P Goetz, Heidi A McKean, Joel M Reid, et al.
Human Immunology|June 18, 2020
Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA typeAnn M Moyer, Brian Dukek, Patti Duellman, et al.
Breast Cancer Research and Treatment|October 21, 2024
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108Vered Stearns, Anne ONeill, Bryan P Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2023
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast CancerMatthew P Goetz, Erika P Hamilton, Mario Campone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashesMatthew P Goetz, James M Rae, Vera J Suman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)H H Yoon, N R Foster, J P Meyers, et al.
Pageof 40